Status:
RECRUITING
The Course and Outcome of Integreated Trauma and Addiction Treatment Between PTSD and CPTSD
Lead Sponsor:
IrisZorg
Collaborating Sponsors:
Radboud University Medical Center
Conditions:
PTSD
Addiction
Eligibility:
All Genders
18+ years
Brief Summary
In the ICD-11 post-traumatic stress disorder (PTSD) and complex PTSD (CPTSD) are distinguished. CPTSD is associated with early childhood traumatization and more severe symptom patterns. Research thus ...
Detailed Description
Rationale: In the ICD-11 post-traumatic stress disorder (PTSD) and complex PTSD (CPTSD) are distinguished. CPTSD is associated with early childhood traumatization and more severe symptom patterns. Res...
Eligibility Criteria
Inclusion
- Age ≥18 years. •- Primary diagnosis SUD involving one of the following substances: alcohol, cannabis, cocaine, amphetamine, benzodiazepine, opioid according to the DSM-5 (American Psychiatric Association, 2013), who are receiving or starting outpatient CRA.
- A DSM-5 diagnosis of PTSD (n=25). A DSM-5 diagnosis of PTSD and an additional ICD-11 diagnosis of CPTSD (n=25).
- Planned start of EMDR-therapy within 8 weeks.
- Good Dutch language proficiency (based on clinical judgement).
- Written informed consent
Exclusion
- \-
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06588309
Start Date
September 1 2023
End Date
December 31 2025
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IrisZorg
Arnhem, Netherlands